What is the address of SAMBRE ET SOINS?

The registered office of SAMBRE ET SOINS is located at Rue Ivienne(ST) 53, 6511 Beaumont.

Is SAMBRE ET SOINS still active?

Yes. According to the CBE (30 October 2026) SAMBRE ET SOINS is active, legal situation “Normale toestand”, started on 7 April 2008.

Is SAMBRE ET SOINS registered on Peppol?

Yes, SAMBRE ET SOINS is registered on the Peppol network with ID 0208:0897003738.

What is the enterprise number of SAMBRE ET SOINS?

The enterprise number of SAMBRE ET SOINS is BE0897003738.

When was SAMBRE ET SOINS founded?

SAMBRE ET SOINS was founded on 7 April 2008.

Is SAMBRE ET SOINS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 April 2008; 5 annual accounts filed, latest fiscal year 2025.

How much profit did SAMBRE ET SOINS make in 2025?

SAMBRE ET SOINS posted a profit after taxes of € 5,180 in financial year 2025.

What is the revenue of SAMBRE ET SOINS?

As a small company, SAMBRE ET SOINS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 23,806.

SAMBRE ET SOINS (Private Limited) - Beaumont

Dossier SAMBRE ET SOINS, printed on 30 October 2026 from databakkes.be/en/0897003738/sambre-et-soins. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SAMBRE ET SOINS from Beaumont, company number BE0897003738, closed financial year 2025 with a result of € 5,180 after tax. For that financial year SAMBRE ET SOINS recorded a gross margin of € 23,806 and equity of € 81,494. Compared with financial year 2024, the result moved from € 18,050 to € 5,180. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Healthy

€ 81,494

▼ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 5,180

▼ 71% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 83,988

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 12,554 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 30,123

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 16,360

▼ 24% vs 2024

€ 4,370 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 1,161

▲ € 1,063 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,301

▼ 32% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 19,902 Gross margin 2022: € 19,902 First fiscal year in the series	€ 26,653 Gross margin 2023: € 26,653 ▲ 34% vs 2022 (€ 19,902) Favourable step	€ 39,054 Gross margin 2024: € 39,054 ▲ 47% vs 2023 (€ 26,653) Favourable step	€ 23,806 Gross margin 2025: € 23,806 ▼ 39% vs 2024 (€ 39,054) Unfavourable step	▼ 39%
Profit after taxes	€ 3,026 Profit after taxes 2022: € 3,026 First fiscal year in the series	€ 16,145 Profit after taxes 2023: € 16,145 ▲ € 13,119 vs 2022 (€ 3,026) Favourable step	€ 18,050 Profit after taxes 2024: € 18,050 ▲ 12% vs 2023 (€ 16,145) Favourable step	€ 5,180 Profit after taxes 2025: € 5,180 ▼ 71% vs 2024 (€ 18,050) Unfavourable step	▼ 71%
Equity	€ 95,577 Equity 2022: € 95,577 First fiscal year in the series	€ 98,165 Equity 2023: € 98,165 ▲ 3% vs 2022 (€ 95,577) Favourable step	€ 88,868 Equity 2024: € 88,868 ▼ 9% vs 2023 (€ 98,165) Unfavourable step	€ 81,494 Equity 2025: € 81,494 ▼ 8% vs 2024 (€ 88,868) Unfavourable step	▼ 8%
Total debts	€ 32,617 Total debts 2022: € 32,617 First fiscal year in the series	€ 33,881 Total debts 2023: € 33,881 ▲ 4% vs 2022 (€ 32,617) Unfavourable step	€ 80,004 Total debts 2024: € 80,004 ▲ 136% vs 2023 (€ 33,881) Unfavourable step	€ 56,043 Total debts 2025: € 56,043 ▼ 30% vs 2024 (€ 80,004) Favourable step	▼ 30%
Cash	€ 86,307 Cash 2022: € 86,307 First fiscal year in the series	€ 75,996 Cash 2023: € 75,996 ▼ 12% vs 2022 (€ 86,307) Unfavourable step	€ 78,872 Cash 2024: € 78,872 ▲ 4% vs 2023 (€ 75,996) Favourable step	€ 83,988 Cash 2025: € 83,988 ▲ 6% vs 2024 (€ 78,872) Favourable step	▲ 6%
Retained profit	€ 81,937 Retained profit 2022: € 81,937 First fiscal year in the series	€ 84,525 Retained profit 2023: € 84,525 ▲ 3% vs 2022 (€ 81,937) Favourable step	€ 75,228 Retained profit 2024: € 75,228 ▼ 11% vs 2023 (€ 84,525) Unfavourable step	€ 67,854 Retained profit 2025: € 67,854 ▼ 10% vs 2024 (€ 75,228) Unfavourable step	▼ 10%
Dividend	€ 11,123 Dividend 2022: € 11,123 First fiscal year in the series	€ 13,557 Dividend 2023: € 13,557 ▲ 22% vs 2022 (€ 11,123) Unchanged	€ 27,347 Dividend 2024: € 27,347 ▲ 102% vs 2023 (€ 13,557) Unchanged	€ 12,554 Dividend 2025: € 12,554 ▼ 54% vs 2024 (€ 27,347) Unchanged	▼ 54%
Bank debt	€ 1,489 Bank debt 2022: € 1,489 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 1,489) Favourable step	€ 21,525 Bank debt 2024: € 21,525 Unchanged (€ 0) Unfavourable step	€ 16,360 Bank debt 2025: € 16,360 ▼ 24% vs 2024 (€ 21,525) Favourable step	▼ 24%
Balance sheet total	€ 145,238 Balance sheet total 2022: € 145,238 First fiscal year in the series	€ 149,091 Balance sheet total 2023: € 149,091 ▲ 3% vs 2022 (€ 145,238) Unchanged	€ 185,917 Balance sheet total 2024: € 185,917 ▲ 25% vs 2023 (€ 149,091) Unchanged	€ 154,581 Balance sheet total 2025: € 154,581 ▼ 17% vs 2024 (€ 185,917) Unchanged	▼ 17%

Key figures of SAMBRE ET SOINS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SAMBRE ET SOINS?

What happened at SAMBRE ET SOINS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 20, 2026 New annual accounts for financial year 2025: profit of € 5,180 (▼ 71% vs 2024). filed late Source: NBB ↗
Apr 7, 2008 New establishment in Beaumont. KBO
Apr 7, 2008 Start of the company according to the CBE. KBO

In short

From € 3,026 profit in 2022 to € 5,180 profit in 2025.

Paid € 17,086 in corporate taxes since 2022.

Best year ever: 2024, with € 18,050 profit.

Paid out € 64,581 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Ivienne(ST) 53

6511 Beaumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0897.003.738
VAT number: BE 0897.003.738
Registered office: Rue Ivienne(ST) 53, 6511 Beaumont
Names & denominations: SAMBRE ET SOINS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 7 April 2008
Peppol: Active · Active since 18 Feb 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

SAMBRE ET SOINS

Financials

What happened to SAMBRE ET SOINS?

Establishments

Establishment units

Details

Frequently asked questions